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This study investigated the effects of Neisseria menigitidis W135 infection via intraperitoneal route on 
plasma free tryptophan concentration, brain serotonin and 5-hydroxyindole acetic acid (5-HIAA) levels 
in albino mice fed normal and tryptophan-enriched diets. The kinetics of appearance of viable bacteria 
in the blood, brain and liver following infection were also investigated. The serotoninergic parameters 
were determined by colorimetric and HPLC methods while colony counts were measured by plate 
count technique. Compared to normal diet, the tryptophan-enriched diet resulted in significantly 
(P<0.05) higher level of plasma free tryptophan level irrespective of infection but with time-point 
increase in death score (8.3–66.7%) in the infected mice. Despite dietary tryptophan enrichment, the 
infected mice were also observed to elicit a time-dependent significant (P < 0.05) decrease in brain 
serotonin (253.9–131.4 vs. 262.4–283.7 ng/g tissue) but increase in 5-HIAA (71.8–174.5 ng/g vs. 70.4–
79.6 ng/g tissue) compared to uninfected animals. Establishment of N. meningitidis W135 meningitis in 
mice and subsequent brain serotonin depletion was further found to display a dose-dependent effect at 
6–12 h post infection when inoculation with 104 and 106–107 cfu/ml were compared. Viable bacteria also 
appeared at different time-points in the blood, brain and liver of the infected mice with growths in blood 
and brain exhibiting similar kinetics but a disparity of 0.2–1.2 logarithmic cfu/ml. The results of this 
study strongly support the involvement of altered serotoninergic activity in meningococcal infection 
due to N. meningitidis.  
 





Meningococcal infection due to Neisseria meningitidis 
remains a public health burden in many countries of the 
world where it cumulatively accounts for about 500,000 
clinical cases annually with 50% of such cases and up to 
27,000 deaths occurring in sub-Saharan Africa (Tikhom-
irov et al., 1997). N. meningitidis epidemics within the 
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mitous, characterized by clonal diversity of aetiology 
agents, increased number of cases and case fatality 
rates (CFRs) in the last two decades (Haimanot et al., 
1990; Mohammed et al., 2000). The emergence and 
predominance of N. meningitidis W135 in the early 21st 
century as a significant epidemic serogroup has further 
complicated the management of meningococcal infection 
in developing countries resulting in a multitude of poor 
outcomes and survivors with long-term neurological 
sequelae (Hodgson et al., 2001).  The latter is a 
consequence of neuronal damage inflicted by Neisseria 






erium inflammatory events (Nau, 2003).  
Reports emanating from several animal models of 
experimental meningitis and clinical studies in children 
have validated infections to result in the disruption of 
blood-brain barrier, haemodynamic collapse and loss of 
cerebral blood flow auto-regulation following the invasion 
of sub-arachnoid space coupled with receptor mediated 
activation of cells of the reticuloendothelial system in the 
brain (Moller et al., 2000; Kongstad and Graeme, 2001; 
Park et al., 2003; Nau, 2003). Whereas adjunctive 
treatment of meningitis with dexamethasone prior to 
antibiotic regimen has produced contrasting clinical 
outcomes (de Gans and van de Beek, 2002; Molyneux et 
al., 2002), the use of norepinephrine and DOPA 
(dihydroxy-L-phenylalanine) as a clinical strategy of 
maintaining cerebral blood flow to meet brain increased 
oxygen and energy demand at the expense of increased 
intracranial pressure due to infection has revealed 
tremendous therapeutic benefits in animals and humans 
(Park et al., 2003; Nau, 2003).  Previous studies have 
implicated impairment of sympathetic–adrenal system 
characterized by secretion of catecholamine and 
depletion of adrenal catecholamine store of patients with 
meningitis dead or alive (Glotova and Sirina, 1976; Sirina 
et al., 1978). However, data are lacking to implicate 
catecholamine metabolic dysregulation, which occurs in 
the pathogenesis of meningococcal infection as a 
prognostic marker of neurological deficits: seizures, 
learning and memory impairment and depression often 
observed among survivors (Hodgson et al., 2001). 
Serotonin (5-hydroxytryptamine), a neurotransmitter of 
the serotoninergic neurons regulates mood, memory and 
learning behaviours (Fernstrom and Wurtman, 1971; 
Fernstrom, 1994). The ability of serotonin to modulate 
behaviours has been correlated with the level of the 
neurotransmitter in the plasma and brain (Fernstrom and 
Wurtman, 1972) and lower levels of this neurotransmitter 
have been reported in patients with neurodegenerative 
diseases, depression and those lacking stress coping 
ability (Rosenthal et al., 1989; Maes and Meltzer, 1995; 
Markus et al., 1998). We hypothesize that an 
understanding of the role(s) played by the serotoninergic 
pathways in the pathogenic disposition of N. meningitis 
and host response to infection would improve adjunctive 
management of meningococcal disease and reduce the 
risk of neurological-sequelae among survivors. The 
present study was designed using a mouse model of 
experimental meningitis due to hyper-invasive ST11 
complex N. meningitidis W135 strain, a CFS isolate 
obtained during the 2003 epidemic in Jigawa State 
(Nigeria) in which 230 cases and 133 deaths (Case 
Fatality Rate [CFR] = 57.8%) were reported (Uwah et al., 
personal communication).  The effects of infection on 
plasma tryptophan, brain serotonin levels as well as 
concentration of metabolite 5-hydroxyindole acetic acid 
(5-HIAA) were investigated. 








Adult inbred albino mice weighing 25–28 g (mean weight = 26.4 g) 
were used for this study.  The animals were obtained form the 
Animal House of the Nigerian Institute of Medical Research, Lagos, 
Nigeria. Prior to the experiments, the animals were fed normal diet 
(Ladokun Farms, Ibadan, Nigeria) and water ad libitum. They were 
kept in metabolic cages and observed under 12 h/12 h light/dark 
cycle in a well-ventilated room at 26–27oC.  Experiments were 
performed according to the National Institute of Health Guidelines 





To investigate the effect of dietary tryptophan supplementation on 
the course of N. meningitidis W135 pathogenesis, serotoninergic 
response and survival in mice, a tryptophan enriched diet with 
additional 1.24 g/100 g feed was formulated. The normal diet 
consists of corn starch 64.8%, casein 18.6%, crude fibre 3.2%, corn 
oil 4.5%, vitamin mix 4.0%, mineral mix 4.0%, bile salt 0.1%, DL-
methionine 0.30% and L-cysteine 0.36%.  The enriched diet was 





A N. meningitidis W135 strain recovered from CSF sample during 
meningitis epidemic in Jigawa State in 2003, stored in Trans-Isolate 
(T-I) medium (Ajello et al., 1984) containing 1% VCN (vancomycin-
colistin-nystatin) inhibitor (BBL) in vented bottles at 32-35oC and 
transported to the Central Public Health Laboratory (CPHL), Lagos, 
were used for inducing experimental meningitis in mice in this 
study.  The viability of the organism was tested by growth on 
chocolate agar plates at 37oC for 24 h in 5% CO2 atmosphere. 
Speciation was confirmed based on oxidase reaction, O-
nitrophenyl--D-galactopyranoside test, sugar fermentation 
(Cruishank et al., 1975) and -lactamase test (Bush and Syke, 
1980).  Serotyping, subtyping and electrophoretic typing of the 
isolate was carried by dot blot analysis (Wedege et al., 1990) and 
multilocus electrophoresis (Selander et al., 1986) at the Central 
Laboratory of Norwegian Institute of Public Health, Oslo, Norway.  
For colony forming units (cfu) counts, blood was withdrawn from 
infected mice at different time-points by cardiac puncture before 
sacrifice and added to a tube containing 3.8% of sodium citrate. 
Brains and livers were excised and homogenized in 2 ml of sterile 
PBS (phosphate buffered saline). Bacterial counts in blood, brain 
and liver were performed by plating 10-fold dilutions onto blood-





Infected and control mice were lightly anaesthesized with 
chloroform and then sacrificed by cervical decapitation. For brain 
serotonin and 5-hydroxy indole acetic acid (5-HIAA) determination, 
whole brain tissue of the animal was immediately excised and 
homogenized by sonication with 0.5 – 1.0 ml of 0.1 M perchloric 
acid for 30 s.  The resulting homogenate was centrifuged at 6500 
rpm at 4°C for 15 min followed by collection of supernatant into a 
sterile capped vial bottle. Plasma was prepared by centrifugation at 
3500 rpm for 10 min at 20°C of citrated tail blood of the animals and 
also collected into sterile bottle for immediate use.  
. 




Table 1. Composition of normal and tryptophan-enriched diets for animal feeding. 
 
Composition (g/100 g feed) 
Nutrient Normal Diet Tryptophan – enriched diet 
Casein Protein  18.6 18.6 
Corn Oil 4.5 4.5 
Corn Starch 64.8 63.6 
Crude fibre 3.2 3.2 
Amino acid supplement 
Methionine 0.40 0.40 
Tryptophan - 1.24 
Cysteine 0.36 0.36 
 
Mineral mixa 4.0 4.0 
Vitamin mixb 4.0 4.0 
Bile salt 0.1 0.1 
Total 100.0 100 
Energy Value (Kj/mol)  3266 3264 
 
aVitamin – thiamin 21.74%, riboflavin 19.26%, pyridoxine 12.82%, calcium panthothenate 8.64% and nicotinic acid 24.8%. 
bMinerals – Ca (C2H5O4)2. 5H2O, 35%; CaCO3, 5.06%; CaH2PO4, 14.6%; KHPO4, 6.46%; NaHPO4, H2O, 18.76%; 




Determination of serotoninergic parameters 
 
The serotoninergic parameters estimated were plasma concen-
tration of tryptophan, brain serotonin and 5-hydroxyindole acetic 
acid (5-HIAA) levels. Plasma tryptophan was determined colorime-
trically following reaction with p-dimethylaminobenzaldehyde (p-
DAB) under acidic conditions according to Doppini et al. (1959). 
Brian serotonin and 5-HIAA were determined by high performance 
liquid chromatography (HPLC). 20 µl of sample (supernatant of 
brain homogenate) was injected into HPLC column (Perkin Elmer, 
12460, USA) and sample constituents were mobilized with 0.163 M 
citric acid buffer (pH 3.0) containing 0.02 mM EDTA, 0.69 mM 
sodium octane sulfonic acid, an ion pairing reagent, 4% (v/v) 
acetonitrile and 1.7% (v/v) tetrahydrofurane at 900 psi pressure. 
Serotonin and 5-HIAA were electrochemically detected by oxidant 
at 0.85 V using carbon/Ag-AgCl electrode circuit detector (DXETR-
45 Kyoto, Japan) at emission wave length of 320 nm. The amounts 
of serotonin and 5-HIAA were calculated by comparing their elution 
times (1.80 and 2.15 min, respectively) with those of standards: 
serotonin creatinine phosphate (100 – 700 ng) and 5-hydroxyindole 
acetate-Na (200 – 500 ng).  Both parameters were measured in 





Data were expressed as mean ± SEM and percentages (%).  
Disparities between mean values were analyzed by one-way 
analysis of variance (ANOVA) while differences between 
percentages were evaluated using chi-square (2) test.  Probability 





Effects of experimental meningitis with N. meningitidis 
W135 infection at 104 cfu/ml, and then 105 - 107 cfu/ml on 
serotoninergic parameters in mice have been investi-
gated. Based on infection at 104 cfu/ml, data presented in 
Table 2 revealed a generally higher plasma tryptophan 
concentration in infected and uninfected animals on 
tryptophan-enriched diet compared to animals fed normal 
diet over the 48 h study period. The observed elevated 
plasma tryptophan concentration was further found to be 
time-dependent and elicited significant (P<0.05) disparity 
in infected and uninfected dietary groups from 24 h post-
infection and 9 h post-feeding respectively. At 9–48 h 
post infection, plasma tryptophan concentration in 
uninfected animals fed tryptophan diet (31.6–36.1 ± 2.5 – 
3.6 mg/dl) was observed to be significantly (P<0.05) 
higher than 28.1–33.7 ± 1.3–1.5 mg/dl found in the 
infected mice. 
Time-dependent increase in brain serotonin level 
(262.7–283.7 ng/g tissue) was also observed in 
uninfected mice fed tryptophan-enriched diet. This was 
contrary to the time-dependent reductions in infected 
mice fed with normal (253.7–128.3 ng/g tissue) and 
tryptophan-enriched diets (253.9–131.4 ng/g tissue) 
(Table 3). Whereas, in uninfected group significant 
disparity (P<0.05) in brain serotonin level began in 24 h 
post feeding. This was manifested in all the time points 
over the 48 h study period between uninfected and 
infected animals fed with normal and tryptophan-enriched 
diet (Table 3). 
Results shown in Table 4 revealed increased levels of 
5-HIAA with time from 70.4 – 72.3 ng/g tissue to 79.6 – 
186.4 ng/g tissue in uninfected and infected mice fed 
tryptophan  diet  over  the 48 h study period, respectively.  
. 




Table 2. Effect of dietary tryptophan enrichment on plasma tryptophan concentration in normal and Neisseria 
meningitidis  W135 (104 cfu/ml) infected mice. 
 
Plasma tryptophan concentration (mg/dl) 
Control (uninfected) Infected Time (h) 
Normal diet Tryptophan diet Normal diet Tryptophan diet 
 
N 8 8 12 12 χ2 P 
6 28.4 ± 2.1 (0) 29.2 ± 3.6b (0) 26.8 ± 2.4 (8.3) 27.4 ± 2.6 (16.7)b 0.38 0.54 
9 26.7 ± 1.8 (0) 31.6 ± 2.5ac (0) 27.0 ± 0.8 (16.7) 28.1± 1.3 (17.7)b - - 
12 28.5 ±  3.6 (0) 32.7 ± 1.5ac (0) 26.8 ± 2.4 (33.3) 28.9± 1.8 (33.3)b - - 
24 30.2 ± 3.4 (0) 34.3 ± 2.1ac (0) 28.1± 1.2 (41.7) 30.6 ± 3.1 (33.3)a 0.89 0.35 
36 28.7 ± 2.1 (0) 34.8 ± 3.3ac (0) 28.3 ± 2.1 (50.0) 31.5 ± 1.7 (41.7)a 0.69 0.41 
48 28.1 ± 2.4 (0) 36.1 ± 3.6ac (0) 28.4 ± 1.1 (66.7) 33.7 ± 1.5 (50.0)a 0.69 0.41 
 
N = number of animals per group.  Data are presented as mean ± SEM and analyzed by one-way ANOVA. Figures in 
parentheses are death scores (%) in the experimental animals. Disparity between death scores was analyzed by chi-square 
(χ2) test.  aP<0.05; bP>0.05 (Normal diet vs. Tryptophan diet).  cP<0.05 (Uninfected vs. Infected). 
 
 
Table 3. Effect of dietary tryptophan enrichment on brain serotonin level in normal and Neisseria meningitidis W135 
infected mice. 
 
Brain serotonin level (ng/g tissue) 
Control (uninfected) Infected Time (h) 
Normal diet Tryptophan diet Normal diet Tryptophan diet 
N 8 8 12 12 
6 261.1 ± 23.7 262.7 ± 18.3bc 253.7 ± 19.4 253.9 ± 22.1b 
9 268.4 ± 21.5 270.1 ± 24.6bc 210.4 ± 17.6 212.7± 21.5 b 
12 266.7 ± 36.7 270.4 ± 27.5bc 200.5 ± 22.7 201.4 ± 36.2 b 
24 270.6 ± 31.3 278.4 ± 21.5ac 182.4 ± 31.4 183.7 ± 23.7 b 
36 269.3 ± 23.7 278.6 ± 34.6ac 158.6 ± 27.2 161.7 ± 26.5 b 
48 271.4 ± 28.3 283.7 ± 42.7ac 128.3 ± 17.5 131.4 ± 21.3 b 
 
Data are presented as mean ± SEM and analyzed by one-way ANOVA. N = Number of animals per group. aP<0.05; 
bP>0.05. (Normal diet vs. Tryptophan diet).  cP<0.05 (Uninfected vs. Infected). 
 
 
Table 4. Effect of dietary tryptophan enrichment on brain 5 – hydroxyindole acetic acid (5-HIAA) level in normal and 
Neisseria meningitidis W135 infected mice. 
 
Brain 5- HIAA level (ng/g tissue) 
Control (uninfected) Infected Time (h) 
Normal diet Tryptophan diet Normal diet Tryptophan diet 
N 8 8 12 12 
6 68.4 ± 4.6 70.4 ± 3.3b 72.3 ± 4.1 71.8 ± 1.8bc 
9 70.6 ± 3.1 71.3 ± 2.8 b 86.4 ± 2.8 81.5± 1.4bc 
12 70.8 ± 3.5 73.7 ± 1.8b 114.3 ± 5.2 112.7± 3.6bc 
24 71.5 ± 2.8 76.4 ± 1.7b 120.4 ± 4.3 117.3 ± 3.1bc 
36 70.5 ± 3.3 78.3 ± 2.1a 158.6 ± 7.2 160.5 ± 4.2bc 
48 71.4 ± 2.7 79.6 ± 3.4a 186.4 ± 4.7 174.5 ± 3.4 ac 
 
Data are presented as mean ± SEM and analyzed by one-way ANOVA. N = number of animals per group. aP<0.05; 
bP>0.05. (Normal diet vs. Tryptophan diet).  cP<0.05 (Uninfected vs. Infected). 
 
 
However, the observed variation in brain 5-HIAA levels 
became significant (P<0.05) between uninfected dietary 
groups and infected counterparts from 36 h post-feeding 
(70.5 – 71.4 vs. 78.6 ng/g tissue) and at 48 h post-
infection (186.4 vs. 174.5 ng/g tissue). The level of this 
metabolite  was  further  found to be significantly (P<0.05)  
. 




Table 5. Effect of Neisseria meningitidis W135 load on brain serotonin level in infected mice. 
 
Brain serotonin level (ng/g) 
Control (N = 6) Infectedψ (N = 6 – 12) Time (h) 
 104 105 106 107 
6 262.7 ± 28.5 253.4 ± 17.6 251.4 ± 21.7b 247.9 ± 18.8b 241.2 ± 34.1a 
9 267.6 ± 23.7 212.5 ± 18.4 210.4 ± 17.6b 206.3 ± 17.8b 202.5 ± 15.7a 
12 268.2 ± 31.3 201.7 ± 18.5 198.6 ± 16.5b 197.6± 26.5b 190.4 ± 27.1a 
24 270.2 ± 27.4 182.6 ± 28.6 181.3 ± 28.6b 180.5 ± 18.4b 178.4 ± 28.6a 
36 270.4 ± 22.5 158.4 ± 34.6 156.2 ± 27.8b 155.7 ± 30.1b 153.5 ± 26.2a 
48 271.2 ± 24.5 128.1 ± 23.1 126.3 ± 20.5b 125.7 ± 23.7 b 122.6 ± 18.4a 
 
Data are presented as mean ± SEM and analyzed by one-way ANOVA.  N = number of animals per group.  ψAnimals were 
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Figure 1. Bacterial count variation at three body sites in 
Neisseria meningitidis W135 infected mice. Each data point is a 
logarithmic (Log10) transformed colony forming unit (cfu) of 




higher in infected tryptophan fed mice than their uninfec-
ted counterparts. 
Increment of infective dose of N. meningitidis W135 
from 104 cfu/ml to 105–107 cfu/ml in the animals was 
found to result in significant (P<0.05) reduction in brain 
serotonin only at 9 h post-infection in 106 cfu/ml 
inoculated mice and at 6–12 h in 107 cfu/ml inoculated 
animals when compared to mice infected with 104 cfu/ml 
dose of the bacterial suspension. Infection with 105 cfu/ml 
did not elicit significance (P > 0.05) in brain serotonin 
level compared to 104 cfu/ml-induced infection (Table 5). 
Viable bacteria began to appear at 6, 9 and 36 h post-
infection in the blood, brain and liver of the animals 
infected with 104 cfu/ml of N. meningitidis W135 strain, 
respectively. The kinetics of appearance of the bacterial 
strains in the blood and brain were observed to be similar 
but with difference of 0.2 – 1.2 logarithmic units between 





In addition to increasing morbidity and mortality in 
endemic and epidemic loci in the world, meningococcal 
infection due to the highly virulent N. meningitidis W 135 
has further elevated the risk of neurological sequelae 
dominated by depression, hearing and cognitive impair-
ment among survivors (Tikhomirov et al., 1997; Hodgson 
et al., 2001; Nau, 2003).  Experimental meningitis infec-
tion induced via parenchyma, intercisternal, intranasal, 
subarachnoid and intraperitoneal routes in using rats, 
rabbits, guinea pig and mice as hosts have been emplo-
yed in various studies to improve understanding of 
pathogenesis of meningitis, pathogens’ virulence factors 
diversity and drug efficacy (Tsai et al., 1990; Tan et al., 
1995; Tsao et al., 2002; Hirst et al., 2003; Chiavolini et 
al., 2004). 
The present study has further revealed the alteration in 
serotoninergic pathway following experimental N. menin-
gitidis W135 infection via the intraperitoneal route in 
mice.  Although dietary tryptophan enrichment resulted in 
elevated plasma level of the indole amino acid in infected 
and uninfected animals compared to mice fed with 
normal diets, 8.3–66.9% of the infected animals died 
owing to the lethal infection of N. meningitidis W135.   
Previous studies (Fernstrom and Wurtman, 1971; Ferns-
trom et al., 1979) have revealed the dependence of 






reased ratio of free tryptophan to large amino acids 
(LNAAs) contrary to most protein diets, which contain  
1% tryptophan and 25% LNAAs (i.e. leucine, isoleucine, 
phenylalanine, valine and methionine) (Leiberman et al., 
1986).  It is therefore not surprising that plasma 
tryptophan concentration was elevated in our 
experimental mice fed with diet enriched with 1.24 g/100 
g tryptophan compared to those fed with normal diet 
independent of N. meningitidis W135 infection. However, 
the lower level of plasma tryptophan concentration in 
infected animals compared to uninfected mice despite 
dietary tryptophan fortification may not be unconnected 
with disruption of blood-brain barrier permeability caused 
by N. meningitidis infection (Leib and Tauber, 1999; Nau, 
2003).  A study by Park et al. (2003), in which E. coli 
meningitis was induced via cisternal and intraperitoneal 
routes in newborn piglets, demonstrated pathologically 
the bacterial colonization of nervous tissues, increase in 
intracranial pressure and subsequent decrease cerebral 
blood flow in these animals. Although, the latter possibi-
lity was not investigated in this study, impaired cerebral 
blood flow auto-regulation as a consequence of increa-
sed intracranial pressure, and reduced cerebral blood 
flow as a response to reduced mean arterial pressure has 
been attributed to meningococcal infection and associa-
ted CNS disturbance in several animal and human 
studies (Goiten and Tamir, 1983; Tureen 1989; Tureen et 
al., 1990; Nau, 2003). Meanwhile, improve brain seroto-
nin synthesis and secretion through trypto-phan pyrolase 
dependent pathway and membrane transport (Lovenberg 
et al., 1968) has been associated with increased plasma 
tryptophan concentration, trypto-phan:LNAAs ratio and 
flux of tryptophan from the plasma to the brain through 
the blood-brain barrier (Fenstrom and Fenstrom, 1999). 
Sharp et al. (1995) were able to achieve enhanced 
serotonin release from rat hippocam-pus and improved 
serotoninergic neuronal activity following systemic 
tryptophan administration. Therefore, our observed incre-
ased brain serotonin level in tryptophan diet fed mice is 
an attestation to these findings. However, that brain sero-
tonin level reduced markedly in infected mice may also 
be due to N. meningitidis colonization of the nervous 
tissues, since disruption of blood-brain barrier integrity 
has been implicated in altered kinetics of tryptophan 
transport in several studies (Padridge and Oldendorf, 
1975; Struider and Weicker, 2001). This can be said to 
be complemen-ted by observed elevated 5-HIAA levels in 
the brain homogenate of our infected mice, connoting 
increased serotonin turnover. Reduced brain serotonin 
level due to its biodegradation to its primary metabolite 5-
HIAA has been blamed on hyperactivity of monoamine 
oxidase in patients with depression and neurodegenera-
tive diseases (Carriers and Marco, 2004; Youdim et al., 
2005). Strategies aimed at inhibiting the activity of this 
enzyme have been found to elicit favourable clinical 
outcome (Rascol et al., 2005). The adoption of this strate- 




gy as an adjunct in the management of meningococcal 
infection which demands investigation of the activity and 
kinetic of monoamine oxidase in meningitis is therefore 
suggested. However, it is not clear from the present study 
whether the observed reduced brain serotonin level is a 
generalized pathology or cell type dependent since whole 
brain homogenate was analyzed. This is so because 
previous experimental meningitis studies have 
demonstrated variations in the pattern of pathology and 
inflammatory responses by the dentate gyrus, neocortical 
and context - learning and memory controlled 
hippocampal regions of the brain (Nau, 2003). 
Nevertheless, the appearance of viable bacteria in the 
blood, brain and liver of our infected mice provides a clue 
for possible variation in inter-organ pathology due to N. 
meningitidis W135 infection.  The subsequent alteration 
of serotoninergic pathway emanating from this pathology 
in the brain may further be modulated by the degree of 
infection since significant time-dependent disparity in 
serotonin level was elicited by the pathogen at 104 cfu/ml 
and 105 - 107 cfu/ml in this study.  A related study by 
Chiavolini et al. (2004) revealed colonization of nervous 
tissues and systemic dissemination of mice by S. 
pneumoniae serotypes with time-point variation in cfu 
counts following subarachnoid infection. 
In conclusion, this study has revealed reduced brain 
serotonin level in surviving mice with N. meningitidis 
W135 infection, implicating altered serotoninergic activity 
as one of the mechanisms of neurological sequelae in 
meningococcal infection and may be the basis for 
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